Abstract

Birch pollen allergy affects more than 20% of the European allergic population. On a molecular level, birch pollen allergy can be linked to the two dominant allergens Bet v 1 and Bet v 2. Bet v 2 belongs to the profilin family, which is abundant in the plant kingdom. Importantly, the homologous plant profilins have a conserved cysteine motif with a currently unknown functional relevance. In particular, it is unknown whether the motif is relevant for disulfide formation and to what extent it would affect the profilins’ structural, functional and immunological properties. Here we present crystal structures of Bet v 2 in the reduced and the oxidized state, i.e., without and with a disulfide bridge. Despite overall structural similarity, the two structures distinctly differ at their termini which are stabilized to each other in the oxidized, i.e., disulfide-linked state. These structural differences translate into differences in their proteolytic resistance. Whereas the oxidized Bet v 2 is rather resistant towards the endolysosomal protease cathepsin S, it is rapidly degraded in the reduced form. By contrast, both Bet v 2 forms exhibit similar immunological properties as evidenced by their binding to IgE antibodies from birch pollen allergic patients and by their ability to trigger histamine release in a humanized rat basophilic leukemia cells (RBL) assay, independent of the presence or absence of the disulfide bridge. Taken together our findings suggest that the oxidized Bet v 2 conformation should be the relevant species, with a much longer retention time to trigger immune responses.

Highlights

  • Birch pollen allergy affects over a hundred million people worldwide

  • Bet v 2 is a plant profilin panallergen, i.e., it is ubiquitously distributed throughout nature and shares a highly conserved amino acid sequence of up to 75% even between distantly-related organisms [4]

  • There are two Bet v 2 sequences reported in the protein database designated as profilin-I (P25816) and profilin-II (A4K9Z8)

Read more

Summary

Introduction

Birch pollen allergy affects over a hundred million people worldwide. In Europe, approximately 20% of allergic patients are allergic to birch pollen [1]. Bet v 2 is a plant profilin panallergen, i.e., it is ubiquitously distributed throughout nature and shares a highly conserved amino acid sequence of up to 75% even between distantly-related organisms [4]. This sequence conservation translates into a high similarity of the structural fold and function within other members of the profilin family [5]. It results in a broad IgE cross-reactivity of profilin allergic patients to other inhalant and nutritive allergen sources [6]. The observed differences are independent of the presence of reducing agents, reflecting the conformational differences of Bet v 2 in the presence and the absence of the disulfide bridge

Isolation and Cloning of Bet v 2
Recombinantly-Produced Bet v 2 Exists in Two Conformations
Functional Relevance of the Disulfide Bridge
Materials and Methods
Mass Spectrometry Analyses
Crystallization and Structure Determination
Proteolytic Processing Assay
Patients and Sera
RBL Mediator Release Assay
NMR One-Dimensional Spectrum
4.11. Thermal Shift Assay
4.12. Sequence Alignment and Other Computational Analysis
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.